DE GIORGI, UGO FEDERICO FRANCESCO
DE GIORGI, UGO FEDERICO FRANCESCO
A comprehensive review of the role of immune checkpoint inhibitors in elderly patients affected by renal cell carcinoma
2020 Lolli C.; Altavilla A.; Conteduca V.; Farolfi A.; Casadei C.; Schepisi G.; Banna G.L.; De Giorgi U.
A fully virtual and nationwide molecular tumor board for gynecologic cancer patients: the virtual experience of the MITO cooperative group
2022 Bartoletti M.; Bergamini A.; Giannone G.; Nero C.; Musacchio L.; Farolfi A.; Passarelli A.; Kuhn E.; Castaldo D.; Lombardo V.; Di Palma T.; Lorusso D.; Puglisi F.; De Giorgi U.; Valabrega G.; Schettino C.; Scambia G.; Capoluongo E.; Pignata S.
Adjuvant high-dose chemotherapy with autologous hematopoietic stem cell transplantation for high-risk breast cancer: results from the italian National Registry
2014 Pedrazzoli, Paolo; Martinelli, Giovanni; Gianni, Alessandro Massimo; Da Prada, Gian Antonio; Ballestrero, Alberto; Rosti, Giovanni; Frassineti, Giovanni Luca; Aieta, Michele; Secondino, Simona; Cinieri, Saverio; Fedele, Roberta; Bengala, Carmelo; Bregni, Marco; Grasso, Donatella; De Giorgi, Ugo; Lanza, Francesco; Castagna, Luca; Bruno, Barbara; Martino, Massimo; Gruppo Italiano per il Trapianto di Midollo Osseo, Cellule staminali emopoietiche e terapia cellulare
An update on our ability to monitor castration-resistant prostate cancer dynamics with cell-free DNA
2021 Conteduca V.; Brighi N.; Conteduca D.; Bleve S.; Gianni C.; Schepisi G.; Iaia M.L.; Gurioli G.; Lolli C.; De Giorgi U.
Baseline Plasma Tumor DNA (ctDNA) Correlates with PSA Kinetics in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide
2022 Conteduca V.; Casadei C.; Scarpi E.; Brighi N.; Schepisi G.; Lolli C.; Gurioli G.; Toma I.; Poti G.; Farolfi A.; De Giorgi U.
Bevacizumab as maintenance treatment in patients with ovarian cancer: Wait for BRCA testing
2020 Farolfi A.; Lorusso D.; Pignata S.; De Giorgi U.
CDK4/6-Inhibitors Versus Chemotherapy in Advanced HR+/ HER2-Negative Breast Cancer: Results and Correlative Biomarker Analyses of the KENDO Randomized Phase II Trial
In corso di stampa Francesco Schettini Michela Palleschi , Francesca Mannozzi , Fara Brasó-Maristany , Lorenzo Cecconetto , Patricia Galván , Marita Mariotti , Alessia Ferrari , Emanuela Scarpi , Anna Miserocchi , Oriana Nanni , Esther Sanfeliu , Aleix Prat , Andrea Rocca , Ugo De Giorgi
Cell-Free DNA Fragmentomics: A Promising Biomarker for Diagnosis, Prognosis and Prediction of Response in Breast Cancer
2022 Gianni, Caterina; Palleschi, Michela; Merloni, Filippo; Di Menna, Giandomenico; Sirico, Marianna; Sarti, Samanta; Virga, Alessandra; Ulivi, Paola; Cecconetto, Lorenzo; Mariotti, Marita; De Giorgi, Ugo
Circulating Androgen Receptor for Prognosis and Treatment Selection in Prostate Cancer
2021 Conteduca V.; Wetterskog D.; Gonzalez-Billalabeitia E.; Brighi N.; De Giorgi U.; Attard G.
Circulating inflammatory cells in patients with metastatic breast cancer: Implications for treatment
2022 Gianni C.; Palleschi M.; Schepisi G.; Casadei C.; Bleve S.; Merloni F.; Sirico M.; Sarti S.; Cecconetto L.; Di Menna G.; Schettini F.; De Giorgi U.
Clinical Impact of Next-Generation Sequencing Multi-Gene Panel Highlighting the Landscape of Germline Alterations in Ovarian Cancer Patients
2022 Gurioli, Giorgia; Tedaldi, Gianluca; Farolfi, Alberto; Petracci, Elisabetta; Casanova, Claudia; Comerci, Giuseppe; Danesi, Rita; Arcangeli, Valentina; Ravegnani, Mila; Calistri, Daniele; Zampiga, Valentina; Cangini, Ilaria; Fonzi, Eugenio; Virga, Alessandra; Tassinari, Davide; Rosati, Marta; Ulivi, Paola; De Giorgi, Ugo
Clinical outcome of patients who reduced sunitinib or pazopanib during first-line treatment for advanced kidney cancer
2017 Iacovelli, Roberto*; Cossu Rocca, Maria; Galli, Luca; De Giorgi, Ugo; Sabbatini, Roberto; Santoni, Matteo; Mosca, Alessandra; Fornarini, Giuseppe; Massari, Francesco; Masini, Cristina; Bersanelli, Melissa; Biasco, Elisa; Lolli, Cristian; Guida, Annalisa; Berardi, Rossana; Terrone, Carlo; Pastorino, Alessandro; Ardizzoni, Andrea; Pinto, Carmine; Buti, Sebastiano; Nolè, Franco; Tortora, Giampaolo
Combining liquid biopsy and functional imaging analysis in metastatic castration-resistant prostate cancer helps predict treatment outcome
2021 Conteduca V.; Scarpi E.; Caroli P.; Lolli C.; Gurioli G.; Brighi N.; Poti G.; Farolfi A.; Altavilla A.; Schepisi G.; Matteucci F.; Paganelli G.; De Giorgi U.
Computed tomography based analyses of body mass composition in HER2 positive metastatic breast cancer patients undergoing first line treatment with pertuzumab and trastuzumab
2022 Palleschi M.; Prochowski Iamurri A.; Scarpi E.; Mariotti M.; Maltoni R.; Mannozzi F.; Barone D.; Paganelli G.; Casi M.; Giampalma E.; De Giorgi U.; Rocca A.
Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients
2021 Del Re M.; Omarini C.; Diodati L.; Palleschi M.; Meattini I.; Crucitta S.; Lorenzini G.; Isca C.; Fontana A.; Livi L.; Piacentini F.; Fogli S.; De Giorgi U.; Danesi R.
Enzalutamide for the treatment of nonmetastatic castration-resistant prostate cancer
2020 Altavilla A.; Casadei C.; Lolli C.; Menna C.; Ravaglia G.; Gurioli G.; Farolfi A.; Brighi N.; Conteduca V.; Burgio S.L.; Schepisi G.; Rossi L.; Gargiulo S.; Lisotti I.; De Giorgi U.
Flare phenomenon in prostate cancer: recent evidence on new drugs and next generation imaging
2021 Conteduca V.; Poti G.; Caroli P.; Russi S.; Brighi N.; Lolli C.; Schepisi G.; Romeo A.; Matteucci F.; Paganelli G.; Marchetti P.; De Giorgi U.
Hydroxychloroquine as Prophylaxis for COVID-19: A Review
2020 Monti M.; Vertogen B.; Masini C.; Donati C.; Lilli C.; Zingaretti C.; Musuraca G.; De Giorgi U.; Cerchione C.; Farolfi A.; Cortesi P.; Viale P.; Martinelli G.; Nanni O.
Hypersensitivity to platinum salts according to BRCA status in ovarian cancer: A retrospective analysis of clinical outcomes and systematic review of literature
2021 Giannone G.; Scotto G.; Katsaros D.; De Giorgi U.; Farolfi A.; Borella F.; Cosma S.; Ferrero A.; Mangiacotti S.; Villa M.; Tuninetti V.; Ghisoni E.; Turinetto M.; Mittica G.; Gemmiti S.; Zavallone L.; Aglietta M.; Pasini B.; Di Maio M.; Valabrega G.
Immune system and DNA repair defects in ovarian cancer: Implications for locoregional approaches
2019 Farolfi A.; Gurioli G.; Fugazzola P.; Burgio S.L.; Casanova C.; Ravaglia G.; Altavilla A.; Costantini M.; Amadori A.; Framarini M.; Ansaloni L.; De Giorgi U.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| A comprehensive review of the role of immune checkpoint inhibitors in elderly patients affected by renal cell carcinoma | Lolli C.; Altavilla A.; Conteduca V.; Farolfi A.; Casadei C.; Schepisi G.; Banna G.L.; De Giorgi U. | 2020-01-01 | CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY | - | 1.01 Articolo in rivista | - |
| A fully virtual and nationwide molecular tumor board for gynecologic cancer patients: the virtual experience of the MITO cooperative group | Bartoletti M.; Bergamini A.; Giannone G.; Nero C.; Musacchio L.; Farolfi A.; Passarelli A.; Kuhn ...E.; Castaldo D.; Lombardo V.; Di Palma T.; Lorusso D.; Puglisi F.; De Giorgi U.; Valabrega G.; Schettino C.; Scambia G.; Capoluongo E.; Pignata S. | 2022-01-01 | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | - | 1.04 Replica / breve intervento (e simili) | - |
| Adjuvant high-dose chemotherapy with autologous hematopoietic stem cell transplantation for high-risk breast cancer: results from the italian National Registry | Pedrazzoli, Paolo; Martinelli, Giovanni; Gianni, Alessandro Massimo; Da Prada, Gian Antonio; Ball...estrero, Alberto; Rosti, Giovanni; Frassineti, Giovanni Luca; Aieta, Michele; Secondino, Simona; Cinieri, Saverio; Fedele, Roberta; Bengala, Carmelo; Bregni, Marco; Grasso, Donatella; De Giorgi, Ugo; Lanza, Francesco; Castagna, Luca; Bruno, Barbara; Martino, Massimo; Gruppo Italiano per il Trapianto di Midollo Osseo, Cellule staminali emopoietiche e terapia cellulare | 2014-01-01 | BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | - | 1.01 Articolo in rivista | - |
| An update on our ability to monitor castration-resistant prostate cancer dynamics with cell-free DNA | Conteduca V.; Brighi N.; Conteduca D.; Bleve S.; Gianni C.; Schepisi G.; Iaia M.L.; Gurioli G.; L...olli C.; De Giorgi U. | 2021-01-01 | EXPERT REVIEW OF MOLECULAR DIAGNOSTICS | - | 1.01 Articolo in rivista | - |
| Baseline Plasma Tumor DNA (ctDNA) Correlates with PSA Kinetics in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide | Conteduca V.; Casadei C.; Scarpi E.; Brighi N.; Schepisi G.; Lolli C.; Gurioli G.; Toma I.; Poti ...G.; Farolfi A.; De Giorgi U. | 2022-01-01 | CANCERS | - | 1.01 Articolo in rivista | aseline Plasma Tumor DNA (ctDNA) Correlates with PSA Kinetics in Metastatic Castration-Resistant Prostate Cancer.pdf |
| Bevacizumab as maintenance treatment in patients with ovarian cancer: Wait for BRCA testing | Farolfi A.; Lorusso D.; Pignata S.; De Giorgi U. | 2020-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 1.04 Replica / breve intervento (e simili) | - |
| CDK4/6-Inhibitors Versus Chemotherapy in Advanced HR+/ HER2-Negative Breast Cancer: Results and Correlative Biomarker Analyses of the KENDO Randomized Phase II Trial | Francesco Schettini Michela Palleschi , Francesca Mannozzi , Fara Brasó-Maristany , Lorenzo Cecco...netto , Patricia Galván , Marita Mariotti , Alessia Ferrari , Emanuela Scarpi , Anna Miserocchi , Oriana Nanni , Esther Sanfeliu , Aleix Prat , Andrea Rocca , Ugo De Giorgi | 9999-01-01 | THE ONCOLOGIST | - | 1.01 Articolo in rivista | - |
| Cell-Free DNA Fragmentomics: A Promising Biomarker for Diagnosis, Prognosis and Prediction of Response in Breast Cancer | Gianni, Caterina; Palleschi, Michela; Merloni, Filippo; Di Menna, Giandomenico; Sirico, Marianna;... Sarti, Samanta; Virga, Alessandra; Ulivi, Paola; Cecconetto, Lorenzo; Mariotti, Marita; De Giorgi, Ugo | 2022-01-01 | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | - | 1.01 Articolo in rivista | graphic.pdf; ijms-23-14197.pdf |
| Circulating Androgen Receptor for Prognosis and Treatment Selection in Prostate Cancer | Conteduca V.; Wetterskog D.; Gonzalez-Billalabeitia E.; Brighi N.; De Giorgi U.; Attard G. | 2021-01-01 | EUROPEAN UROLOGY ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Circulating inflammatory cells in patients with metastatic breast cancer: Implications for treatment | Gianni C.; Palleschi M.; Schepisi G.; Casadei C.; Bleve S.; Merloni F.; Sirico M.; Sarti S.; Cecc...onetto L.; Di Menna G.; Schettini F.; De Giorgi U. | 2022-01-01 | FRONTIERS IN ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Clinical Impact of Next-Generation Sequencing Multi-Gene Panel Highlighting the Landscape of Germline Alterations in Ovarian Cancer Patients | Gurioli, Giorgia; Tedaldi, Gianluca; Farolfi, Alberto; Petracci, Elisabetta; Casanova, Claudia; C...omerci, Giuseppe; Danesi, Rita; Arcangeli, Valentina; Ravegnani, Mila; Calistri, Daniele; Zampiga, Valentina; Cangini, Ilaria; Fonzi, Eugenio; Virga, Alessandra; Tassinari, Davide; Rosati, Marta; Ulivi, Paola; De Giorgi, Ugo | 2022-01-01 | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | - | 1.01 Articolo in rivista | Gurioli_Clinical Impact of Next-Generation_2022_october.pdf |
| Clinical outcome of patients who reduced sunitinib or pazopanib during first-line treatment for advanced kidney cancer | Iacovelli, Roberto*; Cossu Rocca, Maria; Galli, Luca; De Giorgi, Ugo; Sabbatini, Roberto; Santoni..., Matteo; Mosca, Alessandra; Fornarini, Giuseppe; Massari, Francesco; Masini, Cristina; Bersanelli, Melissa; Biasco, Elisa; Lolli, Cristian; Guida, Annalisa; Berardi, Rossana; Terrone, Carlo; Pastorino, Alessandro; Ardizzoni, Andrea; Pinto, Carmine; Buti, Sebastiano; Nolè, Franco; Tortora, Giampaolo | 2017-01-01 | UROLOGIC ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Combining liquid biopsy and functional imaging analysis in metastatic castration-resistant prostate cancer helps predict treatment outcome | Conteduca V.; Scarpi E.; Caroli P.; Lolli C.; Gurioli G.; Brighi N.; Poti G.; Farolfi A.; Altavil...la A.; Schepisi G.; Matteucci F.; Paganelli G.; De Giorgi U. | 2021-01-01 | MOLECULAR ONCOLOGY | - | 1.01 Articolo in rivista | Molecular Oncology - 2021 - Conteduca - Combining liquid biopsy and functional imaging analysis in metastatic.pdf; Supplementary materials.zip |
| Computed tomography based analyses of body mass composition in HER2 positive metastatic breast cancer patients undergoing first line treatment with pertuzumab and trastuzumab | Palleschi M.; Prochowski Iamurri A.; Scarpi E.; Mariotti M.; Maltoni R.; Mannozzi F.; Barone D.; ...Paganelli G.; Casi M.; Giampalma E.; De Giorgi U.; Rocca A. | 2022-01-01 | SCIENTIFIC REPORTS | - | 1.01 Articolo in rivista | - |
| Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients | Del Re M.; Omarini C.; Diodati L.; Palleschi M.; Meattini I.; Crucitta S.; Lorenzini G.; Isca C.;... Fontana A.; Livi L.; Piacentini F.; Fogli S.; De Giorgi U.; Danesi R. | 2021-01-01 | ESMO OPEN | - | 1.01 Articolo in rivista | - |
| Enzalutamide for the treatment of nonmetastatic castration-resistant prostate cancer | Altavilla A.; Casadei C.; Lolli C.; Menna C.; Ravaglia G.; Gurioli G.; Farolfi A.; Brighi N.; Con...teduca V.; Burgio S.L.; Schepisi G.; Rossi L.; Gargiulo S.; Lisotti I.; De Giorgi U. | 2020-01-01 | EXPERT OPINION ON PHARMACOTHERAPY | - | 1.01 Articolo in rivista | - |
| Flare phenomenon in prostate cancer: recent evidence on new drugs and next generation imaging | Conteduca V.; Poti G.; Caroli P.; Russi S.; Brighi N.; Lolli C.; Schepisi G.; Romeo A.; Matteucci... F.; Paganelli G.; Marchetti P.; De Giorgi U. | 2021-01-01 | THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY | - | 1.01 Articolo in rivista | 1758835920987654.pdf |
| Hydroxychloroquine as Prophylaxis for COVID-19: A Review | Monti M.; Vertogen B.; Masini C.; Donati C.; Lilli C.; Zingaretti C.; Musuraca G.; De Giorgi U.; ...Cerchione C.; Farolfi A.; Cortesi P.; Viale P.; Martinelli G.; Nanni O. | 2020-01-01 | FRONTIERS IN PHARMACOLOGY | - | 1.01 Articolo in rivista | Hydroxychloroquine as Prophylaxis fo COVID.pdf |
| Hypersensitivity to platinum salts according to BRCA status in ovarian cancer: A retrospective analysis of clinical outcomes and systematic review of literature | Giannone G.; Scotto G.; Katsaros D.; De Giorgi U.; Farolfi A.; Borella F.; Cosma S.; Ferrero A.; ...Mangiacotti S.; Villa M.; Tuninetti V.; Ghisoni E.; Turinetto M.; Mittica G.; Gemmiti S.; Zavallone L.; Aglietta M.; Pasini B.; Di Maio M.; Valabrega G. | 2021-01-01 | GYNECOLOGIC ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Immune system and DNA repair defects in ovarian cancer: Implications for locoregional approaches | Farolfi A.; Gurioli G.; Fugazzola P.; Burgio S.L.; Casanova C.; Ravaglia G.; Altavilla A.; Costan...tini M.; Amadori A.; Framarini M.; Ansaloni L.; De Giorgi U. | 2019-01-01 | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | - | 1.01 Articolo in rivista | - |